The purpose of these molecules (PODS and bifunctional chelators ─ PODS-DFO and PODS-ChxA-DTPA) are to allow the site-selective or site-specific conjugation of proteins and peptides though naturally occurring cysteines or engineered cysteines. Indeed, several studies have demonstrated the superiority of the site-specific conjugation over the random conjugation, in terms of in vivo behavior and pharmacokinetics.
The PODS reagent can be appended by numerous cargo through its terminal primary amine, allowing conjugation of that cargo to the biomolecule (proof of concept with fluorescein), while the bifunctional chelators PODS-DFO and PODS-ChxA”-DTPA allow for further radiolabeling with the positron emitter Zirconium-89 and the beta-emitter Lutetium-177, respectively.
For more information or to license this innovation:
- Log In
to view the innovation's details
- Sign Up
with discount code "ECOS"